GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Grey Wolf Animal Health Corp (TSXV:WOLF) » Definitions » Short Percentage of Float

Grey Wolf Animal Health (TSXV:WOLF) Short Percentage of Float


View and export this data going back to 2022. Start your Free Trial

What is Grey Wolf Animal Health Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Grey Wolf Animal Health's Short Percentage of Float

For the Personal Services subindustry, Grey Wolf Animal Health's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grey Wolf Animal Health's Short Percentage of Float Distribution in the Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Grey Wolf Animal Health's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Grey Wolf Animal Health's Short Percentage of Float falls into.


;
;

Grey Wolf Animal Health Business Description

Traded in Other Exchanges
N/A
Address
100 King Street West, Suite 6000, 1 First Canadian Place,, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp operates as an animal health company. It focuses on improving the lives and well-being of vets and pets in Canada. It has two reportable operating segments: the Animal Health business unit selling, marketing, and distributing pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada. and the Pharmacy business unit compounds pharmaceuticals, for equine use but also the bio-identical hormone replacement therapy market, all based on prescriptions received from veterinarians, physicians, and patients.
Executives
Angela Cechetto Senior Officer
Diane Bourassa Director
Shawn Douglas Aspden Director
Jill Terilee Angevine Director